These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 17524771

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP, Haji SA, Frenkel RE.
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [Abstract] [Full Text] [Related]

  • 3. Intraocular pressure effects of pegaptanib (macugen) injections in patients with and without glaucoma.
    Lanzl IM, Maier M, Feucht N, Lohmann CP, Kotliar KE.
    Am J Ophthalmol; 2008 Jan; 145(1):185; author reply 186. PubMed ID: 18154762
    [No Abstract] [Full Text] [Related]

  • 4. Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection.
    Hariprasad SM, Shah GK, Blinder KJ.
    Am J Ophthalmol; 2006 Jan; 141(1):200-1. PubMed ID: 16387003
    [Abstract] [Full Text] [Related]

  • 5. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.
    Kim JE, Mantravadi AV, Hur EY, Covert DJ.
    Am J Ophthalmol; 2008 Dec; 146(6):930-4.e1. PubMed ID: 18775528
    [Abstract] [Full Text] [Related]

  • 6. Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib.
    Choi DY, Ortube MC, McCannel CA, Sarraf D, Hubschman JP, McCannel TA, Gorin MB.
    Retina; 2011 Jun; 31(6):1028-35. PubMed ID: 21836409
    [Abstract] [Full Text] [Related]

  • 7. Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study.
    Boyer DS, Goldbaum M, Leys AM, Starita C, V.I.S.I.O.N. Study Group.
    Br J Ophthalmol; 2014 Nov; 98(11):1543-6. PubMed ID: 24997182
    [Abstract] [Full Text] [Related]

  • 8. Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin).
    Falkenstein IA, Cheng L, Freeman WR.
    Retina; 2007 Oct; 27(8):1044-7. PubMed ID: 18040242
    [Abstract] [Full Text] [Related]

  • 9. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials.
    VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial GroupDepartment of Ophthalmology, Harvard Medical School, Retina Service, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA. djdamico@meei.harvard.edu, D'Amico DJ, Masonson HN, Patel M, Adamis AP, Cunningham ET, Guyer DR, Katz B.
    Ophthalmology; 2006 Jun; 113(6):992-1001.e6. PubMed ID: 16647134
    [Abstract] [Full Text] [Related]

  • 10. Short-term intraocular pressure changes after intravitreal injection of bevacizumab.
    Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J.
    Can J Ophthalmol; 2007 Dec; 42(6):807-11. PubMed ID: 18026202
    [Abstract] [Full Text] [Related]

  • 11. Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs.
    Carnota-Méndez P, Méndez-Vázquez C, Otero-Villar J, Saavedra-Pazos JA.
    Eur J Ophthalmol; 2014 Dec; 24(5):771-7. PubMed ID: 24706353
    [Abstract] [Full Text] [Related]

  • 12. The effect of intravitreal triamcinolone on intraocular pressure.
    Kramar M, Vu L, Whitson JT, He YG.
    Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
    [Abstract] [Full Text] [Related]

  • 13. Glaucoma filtration surgery following sustained elevation of intraocular pressure secondary to intravitreal anti-VEGF injections.
    Skalicky SE, Ho I, Agar A, Bank A.
    Ophthalmic Surg Lasers Imaging; 2012 Jul 01; 43(4):328-34. PubMed ID: 22788585
    [Abstract] [Full Text] [Related]

  • 14. Safety of intravitreal injections in patients receiving warfarin anticoagulation.
    Dayani PN, Siddiqi OK, Holekamp NM.
    Am J Ophthalmol; 2007 Sep 01; 144(3):451-3. PubMed ID: 17765427
    [Abstract] [Full Text] [Related]

  • 15. Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections.
    Lemos V, Cabugueira A, Noronha M, Abegão Pinto L, Reina M, Branco J, Gomes T.
    Ophthalmologica; 2015 Sep 01; 233(3-4):162-8. PubMed ID: 25791262
    [Abstract] [Full Text] [Related]

  • 16. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L, Allingham RR, Singh I, Stinnett S, Fekrat S.
    J Glaucoma; 2008 Mar 01; 17(2):128-32. PubMed ID: 18344759
    [Abstract] [Full Text] [Related]

  • 17. Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials.
    Bakri SJ, Moshfeghi DM, Francom S, Rundle AC, Reshef DS, Lee PP, Schaeffer C, Rubio RG, Lai P.
    Ophthalmology; 2014 May 01; 121(5):1102-8. PubMed ID: 24393349
    [Abstract] [Full Text] [Related]

  • 18. Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma.
    Agard E, Elchehab H, Ract-Madoux G, Russo A, Lagenaite C, Dot C.
    Can J Ophthalmol; 2015 Apr 01; 50(2):127-31. PubMed ID: 25863852
    [Abstract] [Full Text] [Related]

  • 19. Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration.
    Macugen AMD Study GroupDepartment of Ophthalmology and Visual Sciences, Washington University in St. Louis School of Medicine, St. Louis, Missouri 63110, USA., Apte RS, Modi M, Masonson H, Patel M, Whitfield L, Adamis AP.
    Ophthalmology; 2007 Sep 01; 114(9):1702-12. PubMed ID: 17509689
    [Abstract] [Full Text] [Related]

  • 20. Short-term intraocular pressure trends after intravitreal triamcinolone injection.
    Lee EW, Hariprasad SM, Mieler WF, Newman TL, Apte RS.
    Am J Ophthalmol; 2007 Feb 01; 143(2):365-7. PubMed ID: 17258540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.